ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Primary Objective
- The main objective of this study is to assess if a two-month regimen of irbesartan in
patients hospitalized for acute coronary syndrome without ST segment elevation can
reduce inflammation markers (ie hsCRP), in comparison to a similar regimen of enalapril.
Secondary Objectives
- To compare both regimens on several other biological parameters which have demonstrated
their relevance and their predictive clinical value (ie BNP, microalbuminuria, troponin
I …) in this patient population.
- To compare on the above parameters the early initiation of treatment versus the
initiation of treatment at hospital discharge.